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The five commentaries on our initial article1 provide valuable insights into the complex process of re-framing the relationships involved in provider side decision-
making in the health sector. These commentaries help focus 
more closely on the elements involved in the proposed shifting 
of institutional level decision-making; (i) away from full and 
exclusive dependence on governmental and political bodies, 
at either/or both national and regional level, one of the critical 
elements in the definition of governance; so that (ii) the new 
center of gravity is one or another structural arrangement 
simultaneously more targeted on patients and performance, 
as well as having greater potential to innovate effectively in its 
patient care routines and procedures.
One noticeable pattern in reading across the commentaries 
is in underscoring the importance of penetrating beyond 
formal macro and meso levels of governance, to insure that 
real change occurs in daily operational behavior at the micro 
clinical level, which of course is where patients receive care. 
This “shop-floor” impact was described as essential in order 
to achieve the desired degree of change in both hospital as 
well as primary care outcomes. The near unanimity of the 
comments is a particularly relevant coincidence with the 
original article.
Denis and Usher2 summarized this perception as “good 
governance … also goes deep enough to influence clinical habits,” 
further reinforcing this preferred organizational outcome in 
their last sentence which calls for “going deep and granular 
enough to foster good clinical habits.” Chinitz3 similarly 
concludes that good governance requires the “smooth meeting 
of top-down policy initiatives … with bottom-up innovations 
in micro-delivery systems involving front line staff.” Such 
convergence between clinical habits and good governance is 
of utmost relevance as it incorporates the notion of involving 
clinicians, usually seen as non-central elements in governance 
(see also below).
Back,4 writing about Swedish primary care, further reinforces 
this theme by noting that “it is … important to pay attention 
to the local organizational context, in terms of factors that can 
both prevent and facilitate a real change.” Also writing about 
the Swedish primary care reforms, Jeurissen and Maarse5 open 
a new angle of analysis (ownership of the facilities and the 
related organization) when they conclude that the major shift 
in visiting patterns created by new privately owned primary 
care providers could be contrasted with the fact that “earlier 
reforms to improve the primary care system from within had 
largely failed.” 
Finally, although somewhat less emphatic about reinforcing 
shop-floor authority, Chanturidze and Obermann6 note that 
“good governance … should (permit) leeway for managers 
to be creative in countering unforeseeable needs and 
circumstances.” 
A second point where all five commentaries agree is that 
additional research could help develop this area of study 
further, making the critical point that provider governance 
probably has not received sufficient attention as a research 
topic. One particular aspect that appeared to several 
commentators to require more research concerned the 
mechanisms and outcomes by which macro and meso 
level decision-making altered (or did not alter) micro level 
behavior, including but going beyond clinical behaviour. 
Denis and Usher2 write that “The ‘black box” of clinical 
governance as a process between incentive and outcome 
needs to be unpacked to find the instruments that can support 
improvement at the micro level” implicitly in a complex 
though not unfolded relationship with the meso and macro 
levels above it. Chinitz3 similarly states in a straightforward 
manner that “more work needs to be done to assess the 
implications of governance shifts between the macro and 
meso levels on what happens at the micro level.” 
Paralleling these concerns, the final sentence in the abstract 
by Back4 concludes that “this article calls for research … to 
capture everyday practice in-depth.” In a similar but 
closely related concern, Jeurissen and Maarse5 call for more 
information about the costs of running the new primary care 
model in Sweden, and about the seeming lack of interest across 
Europe in specifically not-for-profit models of innovative care 
delivery. That topic has major relevance for Europe, where 
innovative not-for-profit care has received comparatively less 
attention than other ownership and organizational modalities.
Where there was some difference between several of the 
commentaries and the original article was in the degree to 
which the formal official structures of government should 
continue to dominate over non-governmental private sector 
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actors in the pursuit of governance outcomes. Several of the 
commentaries implicitly argue for continuation of a more 
dominant and coercive national and/or regional government 
decision-making function than did our initial article. Such 
continued reliance on formal government to resolve nearly 
all important dilemmas through restrictive legislation and/
or regulation could be argued to undermine a fundamental 
distinction which underlines the analysis in our original 
article. The vision of formal government acting unilaterally 
as a command-and-control decision-maker is presented in 
our paper in explicit contrast to a broader, more inclusive, 
understanding of governance which combines the actions 
of both private and public decision-makers in the shaping of 
everyday provider behavior and activities through emerging 
relationships that are not captured by the word “government.”
For example, Chanturidze and Obermann6 state that “by 
‘governance,’ we mean all ‘steering’ carried out by public 
bodies that seek to constrain, encourage, or otherwise 
influence acts of private and public parties,” thus, in practice 
eliminating all private sector actors (not-for-profit, group-
practice, and small and large for-profit actors) from any 
effective governance role. Following up on this perspective, 
they subsequently call for “strong governance arrangements” 
by which formal public sector government controls continue 
unilaterally to determine all aspects of private sector health-
related activity (p. 508). 
Overall, there appears to be considerable overlap both of 
analysis and of suggestions for prospective next steps between 
the writers of these commentaries and our original article. It 
may be that working further within this overlapping area can 
help advance our ability to harness the concept of governance 
in the pursuit of more efficient and effective healthcare 
providers.
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